ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 99 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $109,000 | -7.6% | 100,300 | +6.7% | 0.00% | +33.3% |
| Q1 2022 | $118,000 | +31.1% | 94,000 | +67.9% | 0.00% | +50.0% |
| Q4 2021 | $90,000 | -54.8% | 56,000 | -8.2% | 0.00% | -60.0% |
| Q3 2021 | $199,000 | -40.6% | 61,000 | +27.1% | 0.01% | -44.4% |
| Q2 2021 | $335,000 | +252.6% | 48,000 | +6.7% | 0.01% | +200.0% |
| Q1 2021 | $95,000 | – | 45,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 65,714 | $47,636 | 0.04% |
| Laurion Capital Management LP | 2,225,800 | $1,613,482 | 0.01% |
| ETF MANAGERS GROUP, LLC | 42,442 | $30,766 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,245 | 0.00% |
| Renaissance Technologies | 936,070 | $679 | 0.00% |
| Caption Management, LLC | 75,000 | $54,368 | 0.00% |
| St. Johns Investment Management Company, LLC | 1,550 | $1,124 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 10,621 | $7,699 | 0.00% |
| D. E. Shaw & Co., Inc. | 823,362 | $596,855 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,023 | $3,642 | 0.00% |